ATOSSA THERAPEUTICS, INC. (ATOS) Operating cash flow 2016–2025
ATOSSA THERAPEUTICS, INC. (ATOS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$29.8MFY2025 · since FY2016: -$5.4M → -$29.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.8M | -41.5% |
| FY2024 | -$21.0M | -0.4% |
| FY2023 | -$20.9M | -0.9% |
| FY2022 | -$20.8M | -26.0% |
| FY2021 | -$16.5M | -42.4% |
| FY2020 | -$11.6M | -26.7% |
| FY2019 | -$9.1M | -1.9% |
| FY2018 | -$9.0M | -35.9% |
| FY2017 | -$6.6M | -22.7% |
| FY2016 | -$5.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice